Kotak Healthcare Fund Direct Growth

Fund Overview

Fund Size

₹825 Cr

Expense Ratio

1.04%

ISIN

INF174KA1PZ7

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

11 Dec 2023

About this fund

Kotak Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Kotak Mahindra Mutual Fund. This fund has been in existence for 2 years, 10 months and 11 days, having been launched on 11-Dec-23.
As of 21-Oct-26, it has a Net Asset Value (NAV) of ₹16.52, Assets Under Management (AUM) of 825.14 Crores, and an expense ratio of 1.04%.

Kotak Healthcare Fund Direct Growth has given a CAGR return of 19.18% since inception.
The fund's asset allocation comprises around 98.70% in equities, 0.00% in debts, and 1.30% in cash & cash equivalents.
You can start investing in Kotak Healthcare Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+15.93%

+6.87% (Cat Avg.)

Since Inception

+19.18%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2026

Equity	₹814.43 Cr	98.70%
Others	₹10.71 Cr	1.30%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹109 Cr	13.21%
Divi's Laboratories Ltd	Equity	₹77.12 Cr	9.35%
Molbio Diagnostics Ltd	Equity	₹41.88 Cr	5.08%
Torrent Pharmaceuticals Ltd	Equity	₹38.4 Cr	4.65%
Acutaas Chemicals Ltd	Equity	₹34.43 Cr	4.17%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹29.75 Cr	3.61%
Cipla Ltd	Equity	₹26.92 Cr	3.26%
Park Medi World Ltd	Equity	₹26.12 Cr	3.17%
Gland Pharma Ltd	Equity	₹26.09 Cr	3.16%
Yatharth Hospital and Trauma Care Services Ltd	Equity	₹25.71 Cr	3.12%
Triparty Repo	Cash - Repurchase Agreement	₹24.8 Cr	3.01%
Apollo Hospitals Enterprise Ltd	Equity	₹24.5 Cr	2.97%
Sai Life Sciences Ltd	Equity	₹24.39 Cr	2.96%
Laurus Labs Ltd	Equity	₹23.76 Cr	2.88%
Mankind Pharma Ltd	Equity	₹22.53 Cr	2.73%
Krishna Institute of Medical Sciences Ltd	Equity	₹22.39 Cr	2.71%
Marksans Pharma Ltd	Equity	₹20.14 Cr	2.44%
Anthem Biosciences Ltd	Equity	₹19.32 Cr	2.34%
Fortis Healthcare Ltd	Equity	₹19.25 Cr	2.33%
Prasol Chemicals Ltd	Equity	₹18.48 Cr	2.24%
Ajanta Pharma Ltd	Equity	₹16.29 Cr	1.97%
Rubicon Research Ltd	Equity	₹16.19 Cr	1.96%
Emcure Pharmaceuticals Ltd	Equity	₹14.57 Cr	1.77%
Aurobindo Pharma Ltd	Equity	₹14.21 Cr	1.72%
Viyash Scientific Ltd	Equity	₹14.15 Cr	1.71%
Net Current Assets/(Liabilities)	Cash	₹-14.09 Cr	1.71%
Orchid Pharma Ltd	Equity	₹12.96 Cr	1.57%
Corona Remedies Ltd	Equity	₹12.56 Cr	1.52%
Innova Captab Ltd	Equity	₹11.6 Cr	1.41%
Jubilant Ingrevia Ltd Ordinary Shares	Equity	₹11.1 Cr	1.35%
Jubilant Pharmova Ltd	Equity	₹10.32 Cr	1.25%
Rainbow Childrens Medicare Ltd	Equity	₹9.2 Cr	1.11%
Dr. Lal PathLabs Ltd	Equity	₹8.74 Cr	1.06%
Zydus Lifesciences Ltd	Equity	₹8.72 Cr	1.06%
Metropolis Healthcare Ltd	Equity	₹8.13 Cr	0.98%
Lupin Ltd	Equity	₹8.12 Cr	0.98%
Pfizer Ltd	Equity	₹7.36 Cr	0.89%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹750.41 Cr	90.94%
Basic Materials	₹64.02 Cr	7.76%

Risk & Performance Ratios

Fund Managers

Abhishek Bisen

Since December 2023

Dhananjay Tikariha

Since March 2024

Additional Scheme Detailsas of 30th September 2026

ISIN

INF174KA1PZ7

Expense Ratio

1.04%

Exit Load

No Charges

Fund Size

₹825 Cr

Age

2 years 10 months

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

Nifty Healthcare PR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty Pharma ETF Very High Risk	-	-	-	-
Invesco India Pharma and Healthcare Fund Regular Growth Very High Risk	-	0.0%	₹435.52 Cr	-
Invesco India Pharma and Healthcare Fund Direct Growth Very High Risk	-	0.0%	₹435.52 Cr	-
DSP Nifty Healthcare ETF Very High Risk	0.2%	-	₹17.06 Cr	3.6%
Groww BSE Hospitals ETF Very High Risk	0.5%	-	₹159.92 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.3%	-	₹15.36 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	1.2%	0.0%	₹326.54 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹326.54 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	1.2%	1.0%	₹487.35 Cr	3.6%
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.3%	1.0%	₹487.35 Cr	1.9%
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.6%	1.0%	₹405.14 Cr	9.0%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹405.14 Cr	10.9%
PGIM India Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹130.33 Cr	13.0%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹130.33 Cr	11.2%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹926.55 Cr	9.7%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹926.55 Cr	11.6%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
Kotak Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹825.14 Cr	15.9%
Kotak Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹825.14 Cr	14.1%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.1%	1.0%	₹3501.37 Cr	15.5%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹3501.37 Cr	16.8%
Nippon India Pharma Fund Direct Growth Very High Risk	1.0%	1.0%	₹9166.40 Cr	3.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	2.1%	1.0%	₹6861.20 Cr	-0.1%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.3%	1.0%	₹6861.20 Cr	0.7%
DSP Healthcare Fund Direct Growth Very High Risk	0.8%	0.0%	₹3750.04 Cr	11.2%
DSP Healthcare Fund Regular Growth Very High Risk	2.0%	0.0%	₹3750.04 Cr	9.7%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹99.36 Cr	4.8%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.7%	1.0%	₹99.36 Cr	3.4%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹424.53 Cr	10.7%
quant Healthcare Fund Regular Growth Very High Risk	3.1%	1.0%	₹424.53 Cr	8.9%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1429.84 Cr	8.0%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹5870.00 Cr	9.3%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.4%	0.0%	₹1511.49 Cr	-1.7%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹1511.49 Cr	-0.3%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.2%	-	₹231.43 Cr	3.7%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	2.0%	0.0%	₹5870.00 Cr	8.2%
Nippon India Pharma Fund Regular Growth Very High Risk	1.8%	1.0%	₹9166.40 Cr	2.3%
UTI Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹1429.84 Cr	7.0%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹23.07 Cr	3.5%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1736.44 Cr	14.3%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	2.0%	1.0%	₹3494.44 Cr	9.7%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.6%	1.0%	₹3494.44 Cr	11.3%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹266.05 Cr	1.2%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹266.05 Cr	3.0%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹74.67 Cr	3.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1077.52 Cr	6.8%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹1077.52 Cr	8.3%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.4%	-	₹44.40 Cr	5.0%

About the AMC

Kotak Mahindra Mutual Fund

+91 22 61152100

https://www.kotakmf.com/

Total AUM

₹6,46,073 Cr

Address

2nd Floor, 12-BKC, Plot No C-12, Mumbai, 400 051

Other Funds by Kotak Mahindra Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Kotak Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Capital Markets Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Kotak Multi Sector Omni FOF Direct Growth Very High Risk	-	0.0%	₹21.34 Cr	-
Kotak Nifty Bank Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹6.92 Cr	-
Kotak Diversified Equity All Cap Omni FOF Direct Growth Low Risk	0.1%	0.0%	₹516.63 Cr	-
Infinity Hybrid Long-Short Fund Direct Growth Low to Moderate Risk	2.1%	0.0%	-	-
Kotak Nifty Alpha Low-Volatility 30 Index Fund Direct Growth Very High Risk	1.3%	0.0%	₹7.16 Cr	-
Kotak Multi Asset Active FOF Direct Growth Very High Risk	0.3%	1.0%	₹78.65 Cr	-
Kotak Quality Overseas Equity Omni FOF Direct Growth Very High Risk	0.5%	1.0%	₹404.36 Cr	-
Kotak Multi Factor Passive FOF Direct Growth Very High Risk	0.2%	0.0%	₹151.29 Cr	-
Kotak Services Fund Direct Growth Very High Risk	1.3%	0.0%	₹710.88 Cr	-
Kotak Nifty200 Value 30 Index Fund Direct Growth Very High Risk	1.1%	0.0%	₹12.94 Cr	-
Kotak Dividend Yield Fund Direct Growth Very High Risk	1.1%	1.0%	₹272.83 Cr	-
Kotak Nifty500 Momentum 50 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹26.53 Cr	-
Kotak Rural Opportunities Fund Direct Growth Very High Risk	0.9%	0.0%	₹707.58 Cr	-
Kotak Gold Silver Passive FOF Direct Growth Very High Risk	0.2%	0.0%	₹1104.32 Cr	-
Kotak CRISIL-IBX Financial Services 9 to 12 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹1105.74 Cr	6.0%
Kotak Active Momentum Fund Direct Growth Very High Risk	1.7%	0.0%	₹1590.18 Cr	-0.5%
Kotak Nifty Alpha 50 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹55.37 Cr	0.3%
Kotak Nifty AAA Bond Financial Services Mar 2028 Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹286.49 Cr	5.1%
Kotak Nifty 200 Quality 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹16.39 Cr	-8.2%
Kotak Nifty Top 10 Equal Weight Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹37.47 Cr	-14.1%
Kotak Energy Opportunities Fund Direct Growth Very High Risk	1.1%	0.0%	₹264.49 Cr	-3.1%
Kotak Nifty Midcap 150 Index Fund Regular Growth Very High Risk	0.4%	0.0%	₹46.05 Cr	-3.1%
Kotak CRISIL-IBX Financial Services 3-6 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹236.47 Cr	6.5%
Kotak Nifty Commodities Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹283.32 Cr	-2.4%
Kotak CRISIL-IBX AAA Bond Financial Services Index - Dec 2026 Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹89.84 Cr	6.6%
Kotak BSE Sensex Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹24.74 Cr	-12.0%
Kotak Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹86.57 Cr	-0.7%
Kotak Nifty 100 Equal Weight Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹47.64 Cr	-4.0%
Kotak Nifty 50 Equal Weight Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹71.49 Cr	-6.0%
Kotak Transportation & Logistics Fund Direct Growth Very High Risk	1.1%	0.0%	₹544.55 Cr	-1.2%
Kotak MNC Fund Direct Growth Very High Risk	0.9%	0.0%	₹2246.36 Cr	8.6%
Kotak Nifty Midcap 150 Momentum 50 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹446.51 Cr	-5.8%
Kotak Nifty India Tourism Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹36.52 Cr	-18.4%
Kotak Crisil-IBX AAA Financial Services Index - Sep 2027 Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹606.31 Cr	5.7%
Kotak Nifty Midcap 50 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹82.87 Cr	-1.7%
Kotak BSE PSU Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹75.62 Cr	-3.5%
Kotak Special Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹1920.37 Cr	8.5%
Kotak Nifty 100 Low Volatility 30 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹102.18 Cr	-9.9%
Kotak Fixed Maturity Plan Series 330 - 98 Days Direct Growth Low Risk	-	0.0%	-	-
Kotak Nifty AAA Bond Jun 2025 HTM Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹102.05 Cr	7.5%
Kotak Fixed Maturity Plan Series 329 - 90 Days Direct Growth Low to Moderate Risk	-	0.0%	-	-
Kotak Long Duration Fund Direct Growth Moderate Risk	0.3%	0.0%	₹48.86 Cr	-1.4%
Kotak Technology Fund Direct Growth Very High Risk	1.1%	0.0%	₹478.86 Cr	-5.6%
Kotak Fixed Maturity Plan Series 328 - 90 Days Direct Growth Moderate Risk	-	0.0%	₹144.91 Cr	-
Kotak FMP Series 327 Direct Growth Moderately High risk	-	0.0%	₹206.03 Cr	-
Kotak FMP Series 326 - 175 Days Direct Growth Moderate Risk	-	-	-	-
Kotak FMP Series 325 - 90 Days Direct Growth Moderate Risk	-	0.0%	-	-
Kotak FMP Series 324 - 109 Days Direct Growth Moderately High risk	-	0.0%	-	-

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Kotak Healthcare Fund Direct Growth?

The NAV of Kotak Healthcare Fund Direct Growth, as of 21-Oct-2026, is ₹16.52.

What is the portfolio composition of Kotak Healthcare Fund Direct Growth?

The fund's allocation of assets is distributed as 98.70% in equities, 0.00% in bonds, and 1.30% in cash and cash equivalents.

Who manages the Kotak Healthcare Fund Direct Growth?

The fund managers responsible for Kotak Healthcare Fund Direct Growth are:-

Abhishek Bisen
Dhananjay Tikariha

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

Kotak Healthcare Fund Direct Growth

Fund Overview